BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 19665247)

  • 1. Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: a meta-analysis.
    Cammà C; Cabibbo G; Bronte F; Enea M; Licata A; Attanasio M; Andriulli A; Craxì A
    J Hepatol; 2009 Oct; 51(4):675-81. PubMed ID: 19665247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response-guided peg-interferon plus ribavirin treatment duration in chronic hepatitis C: meta-analyses of randomized, controlled trials and implications for the future.
    Di Martino V; Richou C; Cervoni JP; Sanchez-Tapias JM; Jensen DM; Mangia A; Buti M; Sheppard F; Ferenci P; Thévenot T
    Hepatology; 2011 Sep; 54(3):789-800. PubMed ID: 21674553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.
    Deltenre P; Louvet A; Lemoine M; Mourad A; Fartoux L; Moreno C; Henrion J; Mathurin P; Serfaty L
    J Hepatol; 2011 Dec; 55(6):1187-94. PubMed ID: 21703195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.
    Bacon BR; Shiffman ML; Mendes F; Ghalib R; Hassanein T; Morelli G; Joshi S; Rothstein K; Kwo P; Gitlin N
    Hepatology; 2009 Jun; 49(6):1838-46. PubMed ID: 19291790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the treatment of patients with non-genotype 1 hepatitis C virus infection.
    Mangia A; Mottola L; Piazzolla V
    Clin Infect Dis; 2013 May; 56(9):1294-300. PubMed ID: 23271787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on retreatment of CHC patients with initial treatment failure].
    Zhang L; Shen G; Zhang YL; Qiu GH; Lu Y; Zhao H; Yang M; Li MH; Xie Y; Cheng J; Xu DZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):304-6. PubMed ID: 23189852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retreatment strategies for the patients with HCV infection].
    Pawłowska M
    Przegl Epidemiol; 2005; 59(2):591-4. PubMed ID: 16190570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retreatment with peginterferon plus ribavirin in chronic hepatitis C patients: our own experiences].
    Roznovský L; Orságová I; Petrousová L; Mrázek J; Kloudová A; Kabieszová L; Kůrková J; Pospísek M
    Klin Mikrobiol Infekc Lek; 2010 Apr; 16(2):73-5. PubMed ID: 20503159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data.
    Cammà C; Bruno S; Schepis F; Lo Iacono O; Andreone P; Gramenzi AG; Mangia A; Andriulli A; Puoti M; Spadaro A; Freni M; Di Marco V; Cino L; Saracco G; Chiesa A; Crosignani A; Caporaso N; Morisco F; Rumi MG; Craxì A
    Gut; 2002 Dec; 51(6):864-9. PubMed ID: 12427791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retreatment of patients who do not respond to initial therapy for chronic hepatitis C.
    Shiffman ML
    Cleve Clin J Med; 2004 May; 71 Suppl 3():S13-6. PubMed ID: 15468612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous interferon therapy: a meta-analysis of controlled and uncontrolled trials.
    Cheng SJ; Bonis PA; Lau J; Pham NQ; Wong JB
    Hepatology; 2001 Jan; 33(1):231-40. PubMed ID: 11124841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon monotherapy of chronic hepatitis C in dialysis patients: meta-analysis of clinical trials.
    Fabrizi F; Dixit V; Messa P; Martin P
    J Viral Hepat; 2008 Feb; 15(2):79-88. PubMed ID: 18184190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon mono-therapy for symptomatic HCV-associated mixed cryoglobulinemia : meta-analysis of clinical studies.
    Fabrizi F; Dixit V; Messa P
    Acta Gastroenterol Belg; 2013 Dec; 76(4):363-71. PubMed ID: 24592538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term re-treatment with interferon and ribavirin combination therapy in patients with chronic hepatitis C who are non-responders to interferon alone: a preliminary study.
    Vega P; Castro A; Hermida M; López Calvo S; Pedreira J
    Scand J Infect Dis; 1999; 31(4):359-61. PubMed ID: 10528873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis.
    García-Álvarez M; Pineda-Tenor D; Jiménez-Sousa MA; Fernández-Rodríguez A; Guzmán-Fulgencio M; Resino S
    Hepatology; 2014 Nov; 60(5):1541-50. PubMed ID: 24975775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a meta-analysis of six prospective randomized controlled trials.
    Desai TK; Jamil LH; Balasubramaniam M; Koff R; Bonkovsky HL
    Dig Dis Sci; 2008 Mar; 53(3):815-22. PubMed ID: 17846887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-treatment of patients with chronic hepatitis C virus genotype 4 infection with pegylated interferon and ribavirin: a meta-analysis.
    Zhang B; Nguyen NH; Yee BE; Yip B; Nguyen MH
    BMJ Open Gastroenterol; 2015; 2(1):e000057. PubMed ID: 26629360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymosin Alpha-1 in Combination with Pegylated Interferon and Ribavirin in Chronic Hepatitis C Patients Who have Failed to Prior Pegylated Interferon and Ribavirin Treatment.
    Baek YH; Lee SW; Yoo HS; Yoon HA; Kim JW; Kim YH; Kim HY; Han SY
    Gut Liver; 2007 Jun; 1(1):87-9. PubMed ID: 20485665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of combined pegylated interferon and ribavirin therapy in Jewish patients of Israel suffering from chronic hepatitis C.
    Delgado JS; Baumfeld Y; Novack V; Monitin S; Jotkowitz A; Etzion O; Fich A
    Hepatol Int; 2011 Dec; 5(4):985-90. PubMed ID: 21553307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?
    Gurusamy KS; Wilson E; Koretz RL; Allen VB; Davidson BR; Burroughs AK; Gluud C
    PLoS One; 2013; 8(12):e83313. PubMed ID: 24349487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.